Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity

Copyright © 2024. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 266(2024) vom: 23. Sept., Seite 110327
Auteur principal: Watany, Mona M (Auteur)
Autres auteurs: Elhosary, Marwa M, El-Horany, Hemat E, El-Horany, Mahmoud E
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Active demyelination IRAK-M Interleukin-1 receptor-associated kinase-3 (IRAK-3) Multiple sclerosis Myeloid differentiation primary response 88 (MyD88) Nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) Relapse Interleukin-1 Receptor-Associated Kinases EC 2.7.11.1 plus... Myeloid Differentiation Factor 88 IRAK3 protein, human NF-kappa B MYD88 protein, human Biomarkers RNA, Messenger